Harvard Bioscience targets 3% to 5% full-year 2026 revenue growth as CMT and China mix shifts gross margin to 57% to 59% — See source for full details.
$HBIO
Price history, market instrument context, member research, and related headlines in one place.
HBIO key statistics
NasdaqCMUSD
52-week range
$3.8081%$9.40
Latest session $7.95–$8.40Harvard Bioscience, Inc. (HBIO) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $8.31, up $0.16 (1.96%) from the previous close of $8.15. It has traded between $7.95 and $8.40 in the latest session. Over the past year it has ranged from $3.80 to $9.40, leaving it in the upper quarter of its 52-week range (81%). Reported volume for the session was 16.6K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Harvard Bioscience beats top-line and bottom-line estimates; gives Q3 and raises FY2026 outlook — See source for full details.
Loading $HBIO research…